Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.62 is 12% below its 5-year average of 1.85, around the middle of its 5-year range (0.61–3.49).
As of the fiscal period ended Tuesday, June 30, 2026. 4.56% above its 12-month average of 1.55.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.62.
CURRENT RATIO
1.62
CURRENT RATIO AVG TTM
1.55
CURRENT RATIO AVG 3Y
1.30
CURRENT RATIO AVG 5Y
1.85
CURRENT RATIO AVG 10Y
5.51
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.56%
CURRENT VS 3Y AVG
+24.75%
CURRENT VS 5Y AVG
-12.42%
CURRENT VS 10Y AVG
-70.51%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 566 covered companies
CURRENT VS SECTOR MEDIAN
-51.46%
vs the sector median at left
Market Cap
$122.26M
Current Ratio
10.21
TTM Avg
11.59
3Y Avg
10.00
5Y Avg
8.96
Market Cap
$120.68M
Current Ratio
0.18
TTM Avg
2.23
3Y Avg
2.69
5Y Avg
2.63
Market Cap
$120.28M
Current Ratio
2.00
TTM Avg
1.45
3Y Avg
1.62
5Y Avg
1.71
Market Cap
$118.02M
Current Ratio
6.49
TTM Avg
6.44
3Y Avg
8.52
5Y Avg
8.53
Market Cap
$116.95M
Current Ratio
13.55
TTM Avg
17.30
3Y Avg
10.78
5Y Avg
9.73
Market Cap
$115.06M
Current Ratio
13.40
TTM Avg
10.04
3Y Avg
7.53
5Y Avg
8.95
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $121.37M | 1.62 | 1.55 | 1.30 | 1.85 |
| enGene Holdings Inc. (ENGN)vs › | $122.26M | 10.21 | 11.59 | 10.00 | 8.96 |
| TuHURA Biosciences, Inc. (HURA)vs › | $120.68M | 0.18 | 2.23 | 2.69 | 2.63 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $120.28M | 2.00 | 1.45 | 1.62 | 1.71 |
| Genelux Corporation (GNLX)vs › | $118.38M | 2.39 | 3.50 | 2.69 | 1.97 |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | 6.49 | 6.44 | 8.52 | 8.53 |
| Entera Bio Ltd. (ENTX)vs › | $128.49M | 8.98 | 5.43 | 7.69 | 7.29 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.95M | 13.55 | 17.30 | 10.78 | 9.73 |
| Coya Therapeutics, Inc. (COYA)vs › | $115.06M | 13.40 | 10.04 | 7.53 | 8.95 |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | 2.70 | 1.66 | 3.23 | 3.69 |
Current Ratio
1.62
Quick Ratio
1.62
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.62 |
| 2026-03-31 | 2.37 |
| 2025-12-31 | 0.72 |
| 2025-09-30 | 1.28 |
| 2025-06-30 | 1.78 |
| 2025-03-31 | 1.23 |
| 2024-12-31 | 0.85 |
| 2024-09-30 | 1.44 |
| 2024-06-30 | 1.14 |
| 2024-03-31 | 1.23 |
| 2023-12-31 | 1.65 |
| 2023-09-30 | 1.37 |
| 2023-06-30 | 2.44 |
| 2023-03-31 | 0.61 |
| 2022-12-31 | 2.49 |
| 2022-09-30 | 1.88 |
| 2022-06-30 | 2.86 |
| 2022-03-31 | 1.99 |
| 2021-12-31 | 3.13 |
| 2021-09-30 | 3.35 |
| 2021-06-30 | 3.49 |
| 2021-03-31 | 4.60 |
| 2020-12-31 | 5.70 |
| 2020-09-30 | 4.83 |
| 2020-06-30 | 9.43 |
| 2020-03-31 | 9.38 |
| 2019-12-31 | 8.83 |
| 2019-09-30 | 12.38 |
| 2019-06-30 | 15.96 |
| 2019-03-31 | 18.71 |
| 2018-12-31 | 13.64 |
| 2018-09-30 | 14.99 |
| 2018-06-30 | 21.26 |
| 2018-03-31 | 17.78 |
| 2017-12-31 | 13.51 |
| 2017-09-30 | 12.40 |
| 2017-06-30 | 0.60 |
| 2017-03-31 | 0.91 |
| 2016-12-31 | 1.91 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
